Serum level of YKL-40 correlates with YKL-40 mRNA expression in liver (Kamal et al. 2006), and was suggested to be a useful non-invasive marker for evaluation of the degree of fibrosis as well as efficiency of therapy in patients with HCV-associated liver disorders (Saitou et al. 2005). Here, CHI3L1 is linked to liver disorder.